295
Prelude Therapeutics Inc
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
204
FY23:
236
FY24:
136
FY25:
106
(positive)
Change from FY21 to FY25
millions USD
FY21:
9.98
FY22:
16.1
FY23:
42.1
FY24:
39.6
FY25:
35.6
Total assets
Change from FY21 to FY25
millions USD
FY21:
305
FY22:
221
FY23:
278
FY24:
176
FY25:
141
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
19.2
FY22:
21.7
FY23:
21.8
FY24:
25.6
FY25:
53.0
(negative)
millions USD
FY21:
0
FY22:
3.36
FY23:
18.7
FY24:
18.4
FY25:
19.7
(positive)
Change from FY21 to FY25
millions USD
FY21:
286
FY22:
195
FY23:
237
FY24:
131
FY25:
68.6
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
305
FY22:
221
FY23:
278
FY24:
176
FY25:
141
All amounts in millions USD